LINAFEXOR
Live / Allowed — Publication / registration review complete (as of 19 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79427316
- Mark type
- Stylized text
- Filed
- 27 May 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Priscilla Lauren Speer
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical drugs for medical purposes for the treatment of Metabolic diseases and Inflammation; organotherapy preparations; biological preparations for medical purposes for the treatment of Metabolic diseases and Inflammation; medicines for human purposes for the treatment of Metabolic diseases and Inflammation; chemical preparations for medical purposes for the treatment of Metabolic diseases and Inflammation; surgical implants comprised of living tissues; stem cells for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes
Owner
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Oct 2025 — REFUSAL PROCESSED BY IB
- 13 Oct 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 13 Oct 2025 — REFUSAL PROCESSED BY MPU
- 28 Aug 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 27 Aug 2025 — NON-FINAL ACTION WRITTEN
- 21 Aug 2025 — ASSIGNED TO EXAMINER
- 11 Jul 2025 — APPLICATION FILING RECEIPT MAILED
- 11 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Jul 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB